This week in gene and cell therapy - 26 April 2019

Gene and cell therapy headlines 22 - 26 April

Gene Therapy Leaders Urge Global Moratorium on Germline Editing

A Slower, Gentler CAR T-Cell Therapy? USC Says a Small Study Shows It Could Work

Rexgenero’s Phase III cell therapy trials enter critical phase

Australian gene-editing rules adopt ‘middle ground’

Orchard Therapeutics Announces First Patient Dosed with Cryopreserved Formulation of OTL-103 Gene Therapy for the Treatment of Wiskott-Aldrich Syndrome